Cabergoline
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2389 publications
Correction: Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes.
Journal: Pituitary
Published: August 23, 2026
Functioning pituitary adenomas in pregnancy: updates and controversies.
Journal: Current opinion in endocrinology, diabetes, and obesity
Published: July 27, 2026
Recurrent Pregnancy Loss: Novel Insights and Future Directions.
Journal: Journal of obstetrics and gynaecology of India
Published: July 14, 2026
Evaluation of endothelial dysfunction in women with prolactinoma.
Journal: Pituitary
Published: July 04, 2026
Pituitary tumour shrinkage and diabetic remission in two cats with Cushing syndrome treated with cabergoline.
Journal: The Journal of small animal practice
Published: June 19, 2026
Cardiometabolic effects of sequential prolactin states in dopamine agonist-treated prolactinoma patients: a retrospective longitudinal study.
Journal: Pituitary
Published: June 11, 2026
Recurrent Cushing's disease due to postoperative seeding of tumor cells in the sphenoid sinus: a case report with review of the literature.
Journal: Endocrine journal
Published: June 10, 2026
Last Updated: 09/19/2026